首页|瑞马唑仑联合胸椎旁神经阻滞用于肺癌胸腔镜手术临床评价

瑞马唑仑联合胸椎旁神经阻滞用于肺癌胸腔镜手术临床评价

扫码查看
目的 探讨瑞马唑仑联合胸椎旁神经阻滞(TPVB)用于肺癌胸腔镜手术的临床效果。方法 选取河北省保定市第二医院 2021 年10 月至 2023 年 6 月收治的拟行胸腔镜手术的肺癌患者 122 例,随机分为对照组和观察组,各 61 例。两组患者均行胸腔镜手术并予TPVB,对照组患者予常规麻醉方案,观察组患者予含苯磺酸瑞马唑仑的其他常规麻醉方案。结果 与对照组比较,观察组患者的术毕至拔管时间、引流管留置时间、住院时间均显著缩短,总引流量和补救镇痛患者占比均显著降低(P<0。05)。与对照组比较,观察组患者术后 24 h、术后 72h时的平均动脉压(MAP)和心率(HR)及视觉模拟量表(VAS)评分均显著降低,简易智力状态检查(MMSE)量表评分均显著升高(P<0。05),且观察组患者术后 72h时的心肌肌钙蛋白I、脂质过氧化物酶、C反应蛋白水平均显著降低(P<0。05)。观察组术后不良反应发生率为 8。20%,显著低于对照组的 19。67%(P<0。05)。结论 瑞马唑仑联合TPVB用于肺癌胸腔镜手术,可改善患者的镇痛效果及血流动力学稳定性,减轻认知功能障碍及术后心肌损伤、脂代谢紊乱、炎性反应的程度。
Clinical Evaluation of Remimazolam Combined with Thoracic Paravertebral Block in Thoracoscopic Surgery for Lung Cancer
Objective To investigate the clinical effect of remimazolam combined with thoracic paravertebral block(TPVB)in thoracoscopic surgery for lung cancer.Methods A total of 122 lung cancer patients who planned to undergo thoracoscopic surgery admitted to the NO.2 Hospital of Baoding from October 2021 to June 2023 were selected and randomly divided into the control group and the observation group,with 61 cases in each group.The patients in the two groups all underwent the thoracoscopic surgery and TPVB,the patients in the control group received conventional anesthetic regimen,while the patients in the observation group received other conventional anesthetic regimen including remimazolam besylate.Results Compared with those in the control group,the time from surgery completion to extubation,indwelling time of drainage tube and hospital stay in the observation group significantly shortened,the total drainage volume and proportion of patients receiving rescue analgesia significantly decreased(P<0.05).Compared with those in the control group,the mean arterial pressure(MAP),heart rate(HR)and Visual Analogue Scale(VAS)scores at 24 h and 72 h after surgery in the observation group significantly decreased,and the Mini-Mental State Examination(MMSE)scale scores significantly increased(P<0.05).Compared with those in the control group,the cardiac troponin I(cTnI),lactoperoxidase(LPO)and C-reactive protein(CRP)levels at 72 h after surgery significantly decreased in the observation group(P<0.05).The incidence of postoperative adverse reactions in the observation group was 8.20%,which was significantly lower than 19.67%in the control group(P<0.05).Conclusion Remimazolam combined with TPVB in thoracoscopic surgery for patients with lung cancer can improve the analgesic effects and hemodynamic stability,relieve cognitive impairment,postoperative myocardial injury,lipid metabolism disorders and inflammatory reactions.

lung cancerthoracoscopic surgeryremimazolamthoracic paravertebral blockanalgesic effect

张懿兰、王东亚、何谦、绍伟、李伟、范飒、乔丹

展开 >

河北省保定市第二医院,河北 保定 071000

河北省石家庄市中医院,河北 石家庄 050000

肺癌 胸腔镜手术 瑞马唑仑 胸椎旁神经阻滞 镇痛效果

河北省保定市科技计划

2041ZF206

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(12)